Passage Bio Ownership | Who Owns Passage Bio?

Passage Bio Ownership Summary

Passage Bio is owned by 55.31% institutional investors, 0.21% insiders, and 44.48% retail investors. Lynx1 capital management lp is the largest institutional shareholder, holding 14.99% of PASG shares. Worldwide Healthcare Ord is the top mutual fund, with 3.28% of its assets in Passage Bio shares.

PASG Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Passage Bio	55.31%	0.21%	44.48%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Lynx1 capital management lp	9.26M	14.99%	$5.25M
Vestal point capital, lp	6.10M	9.62%	$2.44M
Orbimed advisors	6.06M	9.55%	$2.42M
New leaf venture partners	2.50M	3.94%	$19.98M
Vanguard group	2.07M	3.35%	$1.17M
Tang capital management	1.50M	2.37%	$600.45K
Renaissance	1.38M	2.24%	$783.43K
Acadian asset management	933.76K	1.47%	$372.00K
Blackrock	817.53K	1.45%	$649.28K
Blackrock funding, inc. /de	594.87K	0.94%	$238.13K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
New leaf venture partners	2.50M	37.74%	$19.98M
Lynx1 capital management lp	9.26M	1.97%	$5.25M
Vestal point capital, lp	6.10M	0.13%	$2.44M
Orbimed advisors	6.06M	0.06%	$2.42M
Tang capital management	1.50M	0.03%	$600.45K
Dlk investment management	53.00K	0.01%	$30.06K
Bridgeway capital management	556.14K	0.01%	$315.39K
Rbf capital	142.81K	0.00%	$57.17K
Renaissance	1.38M	0.00%	$783.43K
Fiduciary trust	215.00K	0.00%	$86.06K

Top Buyers

Holder	Shares	% Assets	Change
Lynx1 capital management lp	9.26M	1.97%	830.00K
Tower research capital llc (trc)	54.48K	0.00%	49.45K
State street	156.77K	-	32.90K
Geode capital management	531.57K	-	22.05K
Xtx topco	60.89K	0.00%	15.49K

Top Sellers

Holder	Shares	% Assets	Change
Versant venture management	-	-	-4.03M
Orbimed advisors	6.06M	0.06%	-979.33K
Acuitas investments	-	-	-471.81K
Affinity asset advisors	-	-	-264.27K
Two sigma advisers, lp	-	-	-209.60K

New Positions

Holder	Shares	% Assets	Change	Value
Two sigma securities	11.72K	0.00%	11.72K	$4.69K
Raymond james financial	6.39K	-	6.39K	$2.56K
Bnp paribas arbitrage, snc	186.00	-	186.00	$105.00
Mid-american wealth advisory group	32.00	-	32.00	$13.00

Sold Out

Holder	Change
Qube research	-4.00
Federation des caisses desjardins du quebec	-10.00
Farther finance advisors	-50.00
Harbour investments	-60.00
Northwestern mutual wealth management	-64.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	39	-4.88%	35,055,187	3.65%	55	1.87%	16	6.67%	11	-
Mar 31, 2025	42	-4.55%	36,319,837	-3.48%	58	1.58%	15	-25.00%	11	10.00%
Dec 31, 2024	13	-70.45%	6,312,660	-83.67%	10	0.26%	5	-72.22%	4	-42.86%
Sep 30, 2024	44	-	38,667,152	2.24%	62	1.39%	19	72.73%	7	-36.36%
Jun 30, 2024	44	-12.00%	37,821,661	-0.07%	67	1.42%	11	-45.00%	11	-15.38%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Worldwide Healthcare Ord	2.03M	3.28%	-
Vanguard US Total Market Shares ETF	1.50M	2.41%	-
Vanguard Total Stock Mkt Idx Inv	73.23K	2.35%	-1.60K
Vanguard Institutional Extnd Mkt Idx Tr	25.59K	0.82%	924.00
Bridgeway Ultra-Small Company	416.04K	0.67%	-
Galileo - Biotech Innovation Fund S USD	412.28K	0.66%	-
Fidelity Extended Market Index	287.91K	0.46%	-751.00
iShares Micro-Cap ETF	101.78K	0.16%	-
Bridgeway Ultra-Small Company Market	90.10K	0.14%	-50.00K
Fidelity Total Market Index	81.32K	0.13%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 11, 2025	Lynx1 Capital Management LP	-	Buy	$2.26K
Sep 15, 2025	Lynx1 Capital Management LP	-	Buy	$83.18K
Sep 12, 2025	Lynx1 Capital Management LP	-	Buy	$138.30K
Jul 23, 2025	Lynx1 Capital Management LP	-	Buy	$283.03K
Jul 24, 2025	Lynx1 Capital Management LP	-	Buy	$379.45K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	6	-
2025 Q2	-	9
2025 Q1	-	7
2024 Q4	4	6
2024 Q3	-	4

PASG Ownership FAQ

Who Owns Passage Bio?

Passage Bio shareholders are primarily institutional investors at 55.31%, followed by 0.21% insiders and 44.48% retail investors. The average institutional ownership in Passage Bio's industry, Biotech Stocks , is 306.59%, which Passage Bio falls below.

Who owns the most shares of Passage Bio?

Passage Bio’s largest shareholders are Lynx1 capital management lp (9.26M shares, 14.99%), Vestal point capital, lp (6.1M shares, 9.62%), and Orbimed advisors (6.06M shares, 9.55%). Together, they hold 34.17% of Passage Bio’s total shares outstanding.

Does Blackrock own Passage Bio?

Yes, BlackRock owns 1.45% of Passage Bio, totaling 817.53K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 649.28K$. In the last quarter, BlackRock decreased its holdings by -105K shares, a -11.38% change.

Who is Passage Bio’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Passage Bio’s biggest shareholder by percentage of total assets invested, with 37.74% of its assets in 2.5M Passage Bio shares, valued at 19.98M$.

Who is the top mutual fund holder of Passage Bio shares?

Worldwide Healthcare Ord is the top mutual fund holder of Passage Bio shares, with 3.28% of its total shares outstanding invested in 2.03M Passage Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools